Tag: Kiran Mazumdar Shaw

The RCSed’s Court of Regents comprises a group of distinguished and accomplished individuals in their field who provide the College with advice and expertise

Continuing to expand its global footprint, the company has completed the integration of the acquired biosimilars business from Viatris in North America (United States and Canada) effective September 1, 2023

The company's revenue in biosimilars is up 114%; research services up 31% and EBITDA at Rs 1,152 crore up 75%

Kiran was speaking at the 20th Anniversary Celebration of the Association of Biotechnology Led Enterprises (ABLE) on April 07, 2023. The theme of the event was "India-A Resilient Global Biotech Destination."

Click to Read: February 2023 Edition of BioVoice eMagazine The Cover Story in the February 2023 issue focuses on the ambitious US$ 300 billion bioeconomy...

Krishnan heads a nine-member executive council that was elected last January for a three-year term starting on April 1, 2021.................

The global index compiled by global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude has been built on the survey of 1,165 biopharma executives and healthcare policymakers across 20 countries..................

The company's agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars will enable access to Trastuzumab and Pegfilgrastim in Africa and Asia...................

A calcineurin inhibitor, Tacrolimus has been particularly effective in treating patients of renal transplant for more than two decades..............

Held by the Centre for Cellular and Molecular Platforms every year to attract, identify and nurture pathbreaking deep science-driven business ideas, the competition is a nationwide search for ideas with significant potential for societal impact in the life sciences domain................